Literature DB >> 15010323

Derivation, propagation and differentiation of human embryonic stem cells.

Brock J Conley1, Julia C Young, Alan O Trounson, Richard Mollard.   

Abstract

Embryonic stem (ES) cells are in vitro cultivated pluripotent cells derived from the inner cell mass (ICM) of the embryonic blastocyst. Attesting to their pluripotency, ES cells can be differentiated into representative derivatives of all three embryonic germ layers (endoderm, ectoderm and mesoderm) both in vitro and in vivo. Although mouse ES cells have been studied for many years, human ES cells have only more recently been derived and successfully propagated. Many biochemical differences and culture requirements between mouse and human ES cells have been described, yet despite these differences the study of murine ES cells has provided important insights into methodologies aimed at generating a greater and more in depth understanding of human ES cell biology. One common feature of both mouse and human ES cells is their capacity to undergo controlled differentiation into spheroid structures termed embryoid bodies (EBs). EBs recapitulate several aspects of early development, displaying regional-specific differentiation programs into derivatives of all three embryonic germ layers. For this reason, EB formation has been utilised as an initial step in a wide range of studies aimed at differentiating both mouse and human ES cells into a specific and desired cell type. Recent reports utilising specific growth factor combinations and cell-cell induction systems have provided alternative strategies for the directed differentiation of cells into a desired lineage. According to each one of these strategies, however, a relatively high cell lineage heterogeneity remains, necessitating subsequent purification steps including mechanical dissection, selective media or fluorescent or magnetic activated cell sorting (FACS and MACS, respectively). In the future, the ability to specifically direct differentiation of human ES cells at 100% efficiency into a desired lineage will allow us to fully explore the potential of these cells in the analysis of early human development, drug discovery, drug testing and repair of damaged or diseased tissues via transplantation.

Entities:  

Mesh:

Year:  2004        PMID: 15010323     DOI: 10.1016/j.biocel.2003.07.003

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  14 in total

1.  Generation and differentiation of microtissues from multipotent precursor cells for use in tissue engineering.

Authors:  Fabian Langenbach; Karin Berr; Christian Naujoks; Andrea Hassel; Michael Hentschel; Rita Depprich; Norbert R Kubler; Ulrich Meyer; Hans-Peter Wiesmann; Gesine Kögler; Jörg Handschel
Journal:  Nat Protoc       Date:  2011-10-13       Impact factor: 13.491

2.  Human fetal liver stromal cells expressing erythropoietin promote hematopoietic development from human embryonic stem cells.

Authors:  Chao Yang; Lei Ji; Wen Yue; Shuang-Shuang Shi; Ruo-Yong Wang; Yan-Hua Li; Xiao-Yan Xie; Jia-Fei Xi; Li-Juan He; Xue Nan; Xue-Tao Pei
Journal:  Cell Reprogram       Date:  2012-02       Impact factor: 1.987

3.  Osteogenic differentiation of stem cells alters vitamin D receptor expression.

Authors:  Rene Olivares-Navarrete; Ken Sutha; Sharon L Hyzy; Daphne L Hutton; Zvi Schwartz; Todd McDevitt; Barbara D Boyan
Journal:  Stem Cells Dev       Date:  2012-01-04       Impact factor: 3.272

Review 4.  Immunological applications of stem cells in type 1 diabetes.

Authors:  Paolo Fiorina; Julio Voltarelli; Nicholas Zavazava
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

5.  Analysis of pluripotent stem cells by using cryosections of embryoid bodies.

Authors:  Ismael C Gomes; Mariana Acquarone; Renata de Moraes Maciel; Rafael Bierig Erlich; Stevens K Rehen
Journal:  J Vis Exp       Date:  2010-12-08       Impact factor: 1.355

6.  Alterations of proliferative and differentiation potentials of human embryonic stem cells during long-term culture.

Authors:  Yong Bin Park; Yoon Young Kim; Sun Kyung Oh; Sun Gan Chung; Seung Yup Ku; Seok Hyun Kim; Young Min Choi; Shin Yong Moon
Journal:  Exp Mol Med       Date:  2008-02-29       Impact factor: 8.718

7.  Glycoproteomic analysis of embryonic stem cells: identification of potential glycobiomarkers using lectin affinity chromatography of glycopeptides.

Authors:  Gerardo Alvarez-Manilla; Nicole L Warren; James Atwood; Ron Orlando; Stephen Dalton; Michael Pierce
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

8.  Laser-assisted blastocyst dissection and subsequent cultivation of embryonic stem cells in a serum/cell free culture system: applications and preliminary results in a murine model.

Authors:  Noriko Tanaka; Takumi Takeuchi; Queenie V Neri; Eric Scott Sills; Gianpiero D Palermo
Journal:  J Transl Med       Date:  2006-05-08       Impact factor: 5.531

9.  Unrestricted somatic stem cells from human umbilical cord blood grow in serum-free medium as spheres.

Authors:  Faten Zaibak; Paul Bello; Jennifer Kozlovski; Duncan Crombie; Haozhi Ang; Mirella Dottori; Robert Williamson
Journal:  BMC Biotechnol       Date:  2009-12-15       Impact factor: 2.563

Review 10.  Overview of micro- and nano-technology tools for stem cell applications: micropatterned and microelectronic devices.

Authors:  Stefano Cagnin; Elisa Cimetta; Carlotta Guiducci; Paolo Martini; Gerolamo Lanfranchi
Journal:  Sensors (Basel)       Date:  2012-11-19       Impact factor: 3.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.